Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CDMO - Moderna Phase 2 Approved And Other News: The Good Bad And Ugly Of Biopharma


CDMO - Moderna Phase 2 Approved And Other News: The Good Bad And Ugly Of Biopharma

Moderna Receives FDA Approval for Phase 2 Studies, Reports Q1 Results

Moderna (MRNA) reported that the FDA has given approval for the start of Phase 2 trial of its Coronovirus vaccine, mRNA-1273. The company is now looking to begin the trial at the earliest. Moderna also reported its Q1 financial numbers and provided business updates. The company is now in the process of finalizing protocol for Phase 3 study of mRNA-1273, which is expected to be initiated in early summer of 2020.

Moderna had filed an IND for the Phase II and later trials of

Read more ...

Stock Information

Company Name: Avid Bioservices Inc.
Stock Symbol: CDMO
Market: NASDAQ
Website: avidbio.com

Menu

CDMO CDMO Quote CDMO Short CDMO News CDMO Articles CDMO Message Board
Get CDMO Alerts

News, Short Squeeze, Breakout and More Instantly...